No Data
No Data
Evercore Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $75
Cantor Fitzgerald Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $100
Vera Therapeutics Pullback a Buying Opportunity, Says Cantor Fitzgerald
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating
Vera Therapeutics' Atacicept Positioned for Growth Amid Market Overreaction to Otsuka's Sibeprenlimab
Vera Therapeutics Selloff Friday Overblown, Says JPMorgan